SARS-CoV-IN-1
Modify Date: 2024-01-09 17:32:56
SARS-CoV-IN-1 structure
|
Common Name | SARS-CoV-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 888958-25-6 | Molecular Weight | 441.69 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H16ClFeN3O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SARS-CoV-IN-1SARS-CoV-IN-1 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-1 shows anti-Coronavirus activity with an EC50 of 4.9 μM in Vero cells. SARS-CoV-IN-1 inhibits the 3D7 and W2 strains of P. falciparum with IC50s of 15.4 and 133.2 nM; and IC90s of 25.7 and 459.1 nM; respectively. Antimalarial and antiviral activities[1]. |
| Name | SARS-CoV-IN-1 |
|---|
| Description | SARS-CoV-IN-1 is an effective inhibitor of SARS-CoV replication. SARS-CoV-IN-1 shows anti-Coronavirus activity with an EC50 of 4.9 μM in Vero cells. SARS-CoV-IN-1 inhibits the 3D7 and W2 strains of P. falciparum with IC50s of 15.4 and 133.2 nM; and IC90s of 25.7 and 459.1 nM; respectively. Antimalarial and antiviral activities[1]. |
|---|---|
| Related Catalog | |
| Target |
EC50: 4.9 μM (SARS-CoV, in Vero cells)[1] IC50: 15.4 nM (3D7 P. falciparum), 133.2 nM (W2 P. falciparum)[1] IC90: 25.7 nM (3D7 P. falciparum), 459.1 nM (W2 P. falciparum)[1] |
| In Vitro | SARS-CoV-IN-1 (Compound 2) inhibits in vitro growth of Plasmodium falciparum far better than Chloroquine (CQ) [1]. |
| References |
| Molecular Formula | C23H16ClFeN3O |
|---|---|
| Molecular Weight | 441.69 |